{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Endocrinology & Hormones > IloprostCAS：78919-13-8
Molecular Formula：C22H32O4
Molecular Weight：360.49
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：Solid
Qty：
Size：
| CAS | 78919-13-8 |
| Name | Iloprost |
| Molecular Formula | C22H32O4 |
| Molecular Weight | 360.49 |
| Solubility | Soluble in DMSO |
| Purity | HPLC≥98% |
| Appearance | Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD00867145 |
| SMILES | O=C(O)CCC/C=C1C[C@@]2([H])C[C@@H](O)[C@H](/C=C/[C@@H](O)C(C)CC#CC)[C@@]2([H])C\1 |
| InChIKey | HIFJCPQKFCZDDL-ACWOEMLNSA-N |
| InChI | InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1 |
| PubChem CID | 5311181 |
| Target Point | Prostaglandin Receptor |
| Passage | Endocrinology & Hormones;GPCR & G Protein |
| Background | It is a stable prostacyclin analog. |
| Biological Activity | Iloprost (ZK 36374; Ciloprost) is a prostacyclin (PGI2) analogue， involves in embryo development and inflammation improvement， and inhibits tumor metastasis. Iloprost can be used for peripheral vascular research[1][2][3][4]. |
| IC50 | IP |
| In Vitro | Prostacyclin (PGI2) is synthesised in oviductal fluid and enhance the embryo development[1].Iloprost is an PGI2 analog， and affects maturation and developmental competence of bovine oocytes[1].Iloprost (0.5 μM; 22-24 h) increases blastocyst rates of bovine embryos as well as proportion of expanded blastocysts[1].Iloprost (0.5 μM; 22-24 h) assists maturation rates and cumulus cell expansion of bovine oocytes， and increases the mRNA expression of genes related to cumulus expansion[1].Iloprost (0.5 μM; 22-24 h) reduces the occurrence of apoptosis in COCs and promotes an anti-apoptotic balance in the transcription of genes involved in apoptosis (BAX and BCL2) [1]. |
| In Vivo | Iloprost (0.3 mg/kg/min; via s.c. mini pumps; 33 d) has a significant anti-metastatic activity in a spontaneously metastasizing tumor model in rat[2].Iloprost (0.2 mg/kg/d; i.p.; 10 d) attenuates hyperoxia effects and reduces inflammation in the newborn mouse lung， with Cyclooxygenase-2 (COX-2/PTGS2) mediates hyperoxia-induced impairment[3].Iloprost (0.2 mg/kg; i.v. or i.p.) exhibits short half-life， and is often administered by means of frequent (every 2-4h) inhalation in treatment[4]. |
| Data Literature Source | [1]. Kowalczyk-Zieba I，et al. Iloprost affects in vitro maturation and developmental competence of bovine oocytes. Theriogenology. 2020 Nov;157:286-296. [2]. Hildebrand M. Pharmacokinetics of iloprost and cicaprost in mice. Prostaglandins. 1992 Nov;44(5):431-42. [3]. Olave N，et al. Iloprost attenuates hyperoxia-mediated impairment of lung development in newborn mice. Am J Physiol Lung Cell Mol Physiol. 2018 Oct 1;315(4):L535-L544. [4]. Schneider MR，et al. Effects of prostacyclin analogues in in vivo tumor models. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:901-8. |
| Unit | Bottle |
| Specification | 1mg 5mg |
是一种稳定的前列环素类似物。
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
